464 related articles for article (PubMed ID: 26184184)
1. Understanding Xeroderma Pigmentosum Complementation Groups Using Gene Expression Profiling after UV-Light Exposure.
Bowden NA; Beveridge NJ; Ashton KA; Baines KJ; Scott RJ
Int J Mol Sci; 2015 Jul; 16(7):15985-96. PubMed ID: 26184184
[TBL] [Abstract][Full Text] [Related]
2. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.
Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF
Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616
[TBL] [Abstract][Full Text] [Related]
3. Xeroderma pigmentosum: from symptoms and genetics to gene-based skin therapy.
Magnaldo T; Sarasin A
Cells Tissues Organs; 2004; 177(3):189-98. PubMed ID: 15388993
[TBL] [Abstract][Full Text] [Related]
4. Functional retroviral vector for gene therapy of xeroderma pigmentosum group D patients.
Carreau M; Quilliet X; Eveno E; Salvetti A; Danos O; Heard JM; Mezzina M; Sarasin A
Hum Gene Ther; 1995 Oct; 6(10):1307-15. PubMed ID: 8590735
[TBL] [Abstract][Full Text] [Related]
5. Prolonged p53 protein accumulation in trichothiodystrophy fibroblasts dependent on unrepaired pyrimidine dimers on the transcribed strands of cellular genes.
Dumaz N; Duthu A; Ehrhart JC; Drougard C; Appella E; Anderson CW; May P; Sarasin A; Daya-Grosjean L
Mol Carcinog; 1997 Dec; 20(4):340-7. PubMed ID: 9433478
[TBL] [Abstract][Full Text] [Related]
6. Spotlight on 'xeroderma pigmentosum'.
Fassihi H
Photochem Photobiol Sci; 2013 Jan; 12(1):78-84. PubMed ID: 23132518
[TBL] [Abstract][Full Text] [Related]
7. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
[TBL] [Abstract][Full Text] [Related]
8. Xeroderma pigmentosum variant with multisystem involvement.
Hessel A; Siegle RJ; Mitchell DL; Cleaver JE
Arch Dermatol; 1992 Sep; 128(9):1233-7. PubMed ID: 1519938
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of nucleotide excision repair defects between XPD-mutated fibroblasts derived from trichothiodystrophy and xeroderma pigmentosum patients.
Nishiwaki T; Kobayashi N; Iwamoto T; Yamamoto A; Sugiura S; Liu YC; Sarasin A; Okahashi Y; Hirano M; Ueno S; Mori T
DNA Repair (Amst); 2008 Dec; 7(12):1990-8. PubMed ID: 18817897
[TBL] [Abstract][Full Text] [Related]
10. Clinical symptoms and DNA repair characteristics of xeroderma pigmentosum patients from Germany.
Thielmann HW; Popanda O; Edler L; Jung EG
Cancer Res; 1991 Jul; 51(13):3456-70. PubMed ID: 2054785
[TBL] [Abstract][Full Text] [Related]
11. Why Cockayne syndrome patients do not get cancer despite their DNA repair deficiency.
Reid-Bayliss KS; Arron ST; Loeb LA; Bezrookove V; Cleaver JE
Proc Natl Acad Sci U S A; 2016 Sep; 113(36):10151-6. PubMed ID: 27543334
[TBL] [Abstract][Full Text] [Related]
12. Sunlight, Vitamin D, and Xeroderma Pigmentosum.
Martens MC; Emmert S; Boeckmann L
Adv Exp Med Biol; 2020; 1268():319-331. PubMed ID: 32918226
[TBL] [Abstract][Full Text] [Related]
13. Correlation of phenotype/genotype in a cohort of 23 xeroderma pigmentosum-variant patients reveals 12 new disease-causing POLH mutations.
Opletalova K; Bourillon A; Yang W; Pouvelle C; Armier J; Despras E; Ludovic M; Mateus C; Robert C; Kannouche P; Soufir N; Sarasin A
Hum Mutat; 2014 Jan; 35(1):117-28. PubMed ID: 24130121
[TBL] [Abstract][Full Text] [Related]
14. Development of a new easy complementation assay for DNA repair deficient human syndromes using cloned repair genes.
Carreau M; Eveno E; Quilliet X; Chevalier-Lagente O; Benoit A; Tanganelli B; Stefanini M; Vermeulen W; Hoeijmakers JH; Sarasin A
Carcinogenesis; 1995 May; 16(5):1003-9. PubMed ID: 7767957
[TBL] [Abstract][Full Text] [Related]
15. Defects in the DNA repair and transcription gene ERCC2 in the cancer-prone disorder xeroderma pigmentosum group D.
Takayama K; Salazar EP; Lehmann A; Stefanini M; Thompson LH; Weber CA
Cancer Res; 1995 Dec; 55(23):5656-63. PubMed ID: 7585650
[TBL] [Abstract][Full Text] [Related]
16. Enzyme defects in xeroderma pigmentosum.
Akiba H; Kato T; Seiji M
J Dermatol; 1976 Aug; 3(4):163-70. PubMed ID: 15633972
[TBL] [Abstract][Full Text] [Related]
17. [Xeroderma pigmentosum].
Ueda M; Ichihashi M
Nihon Rinsho; 1995 Nov; 53(11):2815-20. PubMed ID: 8538050
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of eight groups of xeroderma pigmentosum by genetic complementation using recombinant adenovirus vectors.
Yamashita T; Okura M; Ishii-Osai Y; Hida T
J Dermatol; 2016 Oct; 43(10):1167-1173. PubMed ID: 26971583
[TBL] [Abstract][Full Text] [Related]
19. Evidence for persistent UV-induced DNA damage and altered DNA damage response in xeroderma pigmentosa patient corneas.
Akepogu J; Jakati S; Chaurasia S; Ramachandran C
Exp Eye Res; 2024 Jun; 243():109901. PubMed ID: 38641197
[TBL] [Abstract][Full Text] [Related]
20. Analysis of point mutations in an ultraviolet-irradiated shuttle vector plasmid propagated in cells from Japanese xeroderma pigmentosum patients in complementation groups A and F.
Yagi T; Tatsumi-Miyajima J; Sato M; Kraemer KH; Takebe H
Cancer Res; 1991 Jun; 51(12):3177-82. PubMed ID: 2039995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]